tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Dechert, 6 are a BUY (100%).
Analyst Steve Dechert, currently employed at KEYBANK, carries an average stock price target met ratio of 25% that have a potential upside of 19.59% achieved within 7 days.
Steve Dechert’s has documented 11 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELAN, Elanco Animal Health at 06-Aug-2026.
Analyst best performing recommendations are on LFMD (LIFEMD).
The best stock recommendation documented was for LFMD (LIFEMD) at 4/16/2025. The price target of $7 was fulfilled within 13 days with a profit of $1.97 (39.17%) receiving and performance score of 30.13.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Nov-2025
$30
$7.58 (33.81%)
$29
1 months 15 days ago
(06-Aug-2026)
0/3 (0%)
$5.8 (23.97%)
Buy Since 09-Dec-2024
$33
$10.58 (47.19%)
$27
1 months 15 days ago
(06-Aug-2026)
4/6 (66.67%)
$8.8 (36.36%)
137
Hold Since 29-Jan-2025
$26
$3.58 (15.97%)
$24
1 months 30 days ago
(22-Jul-2026)
13/18 (72.22%)
$0.66 (2.60%)
286
Buy Since 15-Oct-2018
$32
$7.43 (30.24%)
$15
3 months 3 days ago
(18-Jun-2026)
4/6 (66.67%)
$7.78 (32.12%)
56
Buy Since 19-Feb-2026
$30
$5.43 (22.10%)
$28
4 months 14 days ago
(07-May-2026)
4/8 (50%)
$5.99 (24.95%)
710
Which stock is Steve Dechert most bullish on?
What Year was the first public recommendation made by Steve Dechert?
